Page 178 - Orange Book Cumulative Supplement 10 October 2012
P. 178
A - 41
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content
PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
PROPRANOLOL HYDROCHLORIDE - INNOPRAN XL
N021438 002 6500454 Oct 04, 2021 DP
RALTEGRAVIR POTASSIUM - ISENTRESS
N022145 001 M-114 Mar 28, 2015
RALTEGRAVIR POTASSIUM - ISENTRESS
N203045 001 7169780 Oct 03, 2023 DS DP M-114 Mar 28, 2015
7217713 Oct 21, 2022 U-257
7435734 Oct 21, 2022 U-257
7754731 Mar 11, 2029 DS DP U-257
RALTEGRAVIR POTASSIUM - ISENTRESS
N203045 002 7169780 Oct 03, 2023 DS DP M-114 Mar 28, 2015
7217713 Oct 21, 2022 U-257
7435734 Oct 21, 2022 U-257
7754731 Mar 11, 2029 DS DP U-257
REGADENOSON - LEXISCAN
N022161 001 8106029 Jun 22, 2019 U-1042
8106183 Feb 02, 2027 DS
8133879 Jun 22, 2019 DP
8183226 Jun 22, 2019 U-116
REGORAFENIB - STIVARGA
N203085 001 >A> 7351834 Jan 12, 2020 DS NCE Sep 27, 2017
REPAGLINIDE - PRANDIN
N020741 001 6677358 Jun 12, 2018 DS DP U-1265
REPAGLINIDE - PRANDIN
N020741 002 6677358 Jun 12, 2018 DS DP U-1265
REPAGLINIDE - PRANDIN
N020741 003 6677358 Jun 12, 2018 DS DP U-1265
RETAPAMULIN - ALTABAX
N022055 001 RE43390 Apr 12, 2021 DS DP U-805
RIFAXIMIN - XIFAXAN
N021361 001 8158644 Jun 19, 2024 DP
8158781 Jun 19, 2024 DS
8193196 Sep 02, 2027 DS DP
RIFAXIMIN - XIFAXAN
N022554 001 8158644 Jun 19, 2024 DP
8158781 Jun 19, 2024 DS
8193196 Sep 02, 2027 DS DP
RILPIVIRINE HYDROCHLORIDE - EDURANT
N202022 001 8080551 Apr 11, 2023 DS DP
8101629 Aug 09, 2022 DP
RISEDRONATE SODIUM - ATELVIA
N022560 001 8246989 Jan 16, 2026 DP
